BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP. The Sleep-Modulating Peptide Orexin-B Protects Midbrain Dopamine Neurons from Degeneration, Alone or in Cooperation with Nicotine. Mol Pharmacol 2015;87:525-32. [DOI: 10.1124/mol.114.095703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Abu-omar N, Das J, Szeto V, Feng Z. Neuronal Ryanodine Receptors in Development and Aging. Mol Neurobiol 2018;55:1183-92. [DOI: 10.1007/s12035-016-0375-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
2 Barnett S, Li A. Orexin in Respiratory and Autonomic Regulation, Health and Diseases. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 345-63. [DOI: 10.1002/cphy.c190013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pasban-Aliabadi H, Esmaeili-Mahani S, Abbasnejad M. Orexin-A Protects Human Neuroblastoma SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity: Involvement of PKC and PI3K Signaling Pathways. Rejuvenation Res 2017;20:125-33. [PMID: 27814668 DOI: 10.1089/rej.2016.1836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
5 Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochem Int 2020;138:104754. [PMID: 32422324 DOI: 10.1016/j.neuint.2020.104754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zizza M, Di Lorenzo M, Laforgia V, Furia E, Sindona G, Canonaco M, Facciolo RM. Orexin receptor expression is increased during mancozeb-induced feeding impairments and neurodegenerative events in a marine fish. Neurotoxicology 2018;67:46-53. [PMID: 29673962 DOI: 10.1016/j.neuro.2018.04.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lavaur J, Le Nogue D, Lemaire M, Pype J, Farjot G, Hirsch EC, Michel PP. The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons. J Neurochem 2017;142:14-28. [PMID: 28398653 DOI: 10.1111/jnc.14041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
8 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]
9 Aly AE, Waszczak BL. Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier. Expert Opin Drug Deliv 2015;12:1923-41. [PMID: 26289676 DOI: 10.1517/17425247.2015.1069815] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
10 Duda J, Pötschke C, Liss B. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease. J Neurochem 2016;139 Suppl 1:156-78. [PMID: 26865375 DOI: 10.1111/jnc.13572] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 12.7] [Reference Citation Analysis]
11 Bian K, Liu C, Wang Y, Xue Y, Chen L. Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice. Neurosci Lett 2021;765:136291. [PMID: 34666119 DOI: 10.1016/j.neulet.2021.136291] [Reference Citation Analysis]